Product Overview
APHTHOVAC™ 4 is an inactivated hexavalent vaccine for immunization of cloven-hoofed animals against Foot and Mouth Disease.
You are viewing Asia Pacific
APHTHOVAC™ 4
APHTHOVAC™ 4 is an inactivated hexavalent vaccine for immunization of cloven-hoofed animals against Foot and Mouth Disease.
Cattle, buffalo, sheep and goat.
Foot-and-mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed animals. The disease was initially described in the 16th century and was the first animal pathogen identified as a virus. The transboundary spread and significant economic impact have increased the concern of national authorities worldwide to deploy integrated control measures under the frame of National Control Programs.1
The causal agent is the foot-and-mouth disease virus (FMDV) which belongs to the Aphthovirus genus of the Picornaviridae family. Seven serotypes (A, O, C, Asia 1, and South African Territories 1, 2, and 3) have been identified serologically, and multiple subtypes occur within each serotype.1
Traditional FMD vaccines contain defined amounts of one or more chemically inactivated preparations of a seed virus strain blended with a suitable adjuvant and excipients. According to WOAH, commercial FMD vaccines should comply with important criteria: i) formulated with sufficient antigen and appropriate adjuvant to have a minimum potency level of 3 PD50 [50% protective dose]; ii) provide 6 months of immunity after two initial vaccinations given 1-month apart; iii) vaccine strains are selected based on antigenic relationship with circulating strains.2
Aluminum hydroxide and purified saponin.
Active immunization of cloven-hoofed animals to reduce mortality and clinical signs associated with Foot and Mouth Disease (FMD) virus infections.
Animals can be vaccinated from early age, as per advice from your veterinarian.
Zero days for meat and milk.
Some animals may develop swelling at the site of injection. These swellings will disappear within three days.
APHTHOVAC™ 4 is packed and presented in 50 mL (15 doses) and 100 mL (30 doses) polyethylene terephthalate (PET) bottles.
References
1. Grubman and Baxt (2004). Foot-and-Mouth Disease. Clin Microbiol Rev. 2004 Apr; 17(2): 465–493. doi: 10.1128/CMR.17.2.465-493.2004
2. WOAH (2021). Technical Disease Cards. OIE Science Department. Last updated January 2021.
Fill out the form below to connect with Kemin's vaccine experts.
The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.
© Kemin Industries, Inc. and its group of companies All rights reserved. ® ™ Trademarks of Kemin Industries, Inc., USA
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.